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INTRODUCTION
Glycoproteins are involved in many cellular activities, in
embryogenesis and development, and are particularly
important in diseases such as cancer (Brockhausen et al.,
1998). They contain oligosaccharides based on N-
acetylgalactosamine (GalNAc) a -linked to serine or threonine
(O-glycans) and N-acetylglucosamine (GlcNAc) b -linked to
asparagine (N-glycans). Mucins are characterized by an
extremely high content of O-glycans and are subdivided in
secretory and membrane-associated forms (Gendler and
Spicer, 1995). Mucin-like transmembrane glycoproteins have
been found in epithelial and nonepithelial tissues, and can
fulfill a protective role from environmental agents as well as
other biological activities. For example, several membrane-
associated mucins are involved in cell-cell interactions and
mediate leukocyte trafficking, thrombosis and inflammation
(Hilkens et al., 1992; Varki, 1994; Gendler and Spicer, 1995). 
Cancer cells commonly exhibit changes in the expression of
cell-surface mucins or their carbohydrate epitope exposure that
are detected by specific monoclonal antibodies (mAbs)
(Brockhausen et al., 1998). These mucins act as anti-adhesive
molecules due to their large rod-like extracellular domains and
are thought to mediate invasion and metastasis when
overexpressed in carcinoma cells (Kemperman et al., 1994;
Wesseling et al., 1995; Komatsu et al., 1997). 
In a previous work, we described a cell-surface antigen of
about 45 kDa, detected by mAb PA2.26, which is induced in
keratinocytes during mouse epidermal carcinogenesis. PA2.26
antigen is absent from cultured nontumorigenic keratinocytes
and from the normal mouse epidermis but it is expressed by
squamous and spindle carcinoma cell lines, and in tumors
produced in vivo by chemical carcinogenesis. Interestingly, the
antigen is also present in cultured fibroblasts and stromal cells
of the tumors, and it is induced in the skin during tissue
regeneration after wounding and treatment with the tumor
promoter phorbol 12-myristate 13-acetate (PMA) (Gandarillas
et al., 1997).
In this study, we have defined the localization of PA2.26
protein in cultured cells and tissues, and examined its
relationship with the actin cytoskeleton and members of the
ERM (ezrin, radixin, moesin) family protein. Purification of
the antigen by affinity chromatography and peptide sequencing
allowed us to clone the mouse cDNA encoding PA2.26.
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PA2.26 antigen was identified as a cell-surface protein
induced in epidermal carcinogenesis and skin remodeling
processes. PA2.26 is expressed in carcinoma cell lines
and cultured fibroblasts but absent in nontumorigenic
keratinocytes. In tissues, PA2.26 is present in epithelial cells
of the choroid plexus, ependyma, glomerulus and alveolus,
in mesothelial cells, and in endothelia of lymphatic vessels.
Biochemical characterization of PA2.26 protein and
sequence analysis of the isolated cDNA demonstrate
that PA2.26 antigen is a mucin-like transmembrane
glycoprotein. Confocal and immunoelectron microscopy
analysis in cultured cells reveal that PA2.26 is concentrated
in actin-rich microvilli and plasma membrane projections,
such as filopodia, lamellipodia and ruffles, where it
colocalizes with members of the ERM (ezrin, radixin,
moesin) family protein. Ezrin and moesin, but not radixin,
can be coimmunoprecipitated together with PA2.26 from
cell lysates. Ectopic expression of PA2.26 in immortalized,
nontumorigenic, keratinocytes induces an epithelial-
fibroblastoid morphological conversion with increased
plasma membrane extensions, concomitantly to a major
reorganization of the actin cytoskeleton, redistribution of
ezrin to cell-surface projections, and enhanced motility.
These findings suggest an involvement of PA2.26 in cell
migration.
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Sequence analysis of the isolated cDNA, as well as
biochemical characterization of the immunoprecipitated
protein, identified PA2.26 as a small mucin-like
transmembrane glycoprotein of 172 amino acids. In an effort
to gain insights into the function of PA2.26, we have
transfected its cDNA into immortalized keratinocytes which do
not express the antigen. Expression of PA2.26 in these cells
induces a dramatic reorganization of the actin cytoskeleton and
a redistribution of ezrin, concomitantly to a change in cell
morphology from epithelial to fibroblastoid. The PA2.26-
expressing cells acquired migratory properties.
MATERIALS AND METHODS
Cell lines and antibodies
The origins of nontumorigenic MCA3D keratinocytes and mouse
carcinoma cell lines, PDV, HaCa4 and Car C, have been described
elsewhere (Gandarillas et al., 1997). The human keratinocyte cell line
HaCaT (Boukamp et al., 1988) was kindly provided by Dr Norbert
Fusenig (German Cancer Research Center, Heidelberg, Germany).
Cells were grown in Ham’s F-12 medium supplemented with amino
acids, 10% foetal calf serum and antibiotics (2.5 m g/ml amphotericin
B, 100 m g/ml ampicillin, and 32 m g/ml gentamicin; Sigma Chemical
Co., St Louis, MO). Mouse fibroblast cell lines NIH3T3 and Swiss
3T3, and HaCaT keratinocytes, were grown in Dulbecco’s modified
Eagle’s medium containing 10% foetal calf serum and antibiotics.
Cells were maintained on plastic in a humidified, 5% CO2 atmosphere,
at 37°C.
The rat IgG2a mAb PA2.26 was generated in our laboratory by
immunization with whole suspended PDV cells, as previously
described (Gandarillas et al., 1997). Rabbit anti-ezrin, anti-radixin and
anti-moesin polyclonal antibodies were a kind gift from Dr Paul
Mangeat (University of Montpellier, Montpellier, France). The mouse
mAb 3C12 against ezrin was a gift from Dr Ossi Turunen (University
of Helsinki, Helsinki, Finland).
Immunoprecipitation and western blot
Cultured cells were lysed in buffer A (1% Triton X-100, 10 mM
Hepes, pH 6.8, 100 mM NaCl, 2.5 mM MgCl2, 2 mM EGTA) or, when
indicated, in RIPA buffer (0.1% SDS, 0.5% sodium deoxycholate, 1%
Nonidet P-40, 150 mM NaCl, 50 mM Tris-HCl, pH 8.0), and a
cocktail of protease inhibitors (1 mM phenylmethylsulfonyl fluoride,
5 m g/ml aprotinin and 5 m g/ml leupeptin) for 15 minutes at 4°C. The
lysates were precleared with rat IgG covalently coupled to CNBr-
activated Sepharose 4B (Pharmacia Biotech AB, Uppsala, Sweden),
and then immunoprecipitated with mAb PA2.26-Sepharose 4B for 1
hour at 4°C. Immunocomplexes were washed three times in lysis
buffer, eluted by boiling in 10 mM Hepes, pH 6.8, 100 mM NaCl, 2
mM EGTA, 2% SDS, for 5 minutes, and resolved by SDS-PAGE.
After electrophoresis, proteins were transferred from gels to
Immobilon P membranes (Millipore Corp., Bedford, MA). The filters
were exposed to primary antibodies and secondary antibodies coupled
to horseradish peroxidase; Amersham Corp., Arlington Heights, FL).
The peroxidase activity was developed by using an enhanced
chemiluminescence kit (ECL; Amersham Corp.).
Triton X-114 phase separation and phosphatidylinositol-
phospholipase C treatments
PDV cells were homogenized in a buffer containing 10 mM Hepes,
pH 6.8, 100 mM NaCl, 2.5 mM MgCl2, 2 mM EGTA, 0.3 M sucrose,
and clarified by centrifugation. The supernatant was centrifuged at
90000 g for 30 minutes, and the pellet containing the membrane
fraction extracted with Triton X-114 followed by temperature-induced
phase separation, as reported (Bordier, 1981).
For treatment with phosphatidylinositol-phospholipase C (PI-PLC),
subconfluent PDV cultures were cell-surface radiolabeled with
carrier-free 125I (Amersham Corp.), as previously described
(Gandarillas et al., 1997). After labeling, cells were washed in PBS
and incubated with 350 mU/ml of PI-PLC (Boehringer Mannheim) in
serum-free medium for 1 hour at 37°C. As a control, labeled cells
were incubated in medium alone. Culture media were collected, and
cells lysed in buffer A plus protease inhibitors. PA2.26 was
immunoprecipitated from the culture media and cell extracts as
described above. The immunoprecipitates were resolved by 10%
SDS-PAGE under reducing conditions and analyzed by
autoradiography.
Lectin incubation and glycosidase digestions
For detection of glucidic residues, the following digoxigenin-labeled
lectins (Boehringer Mannheim, Mannheim, Germany) were used:
Datura stramonium (DSA), Galanthus nivalis (GNA), Maackia
amurensis (MAA), Sambucus nigra (SNA), Aleuria aurantia (AAA)
and Arachis hypogea (PNA). PA2.26 immunoprecipitates were
resolved by 10% SDS-PAGE and transferred to Immobilon P
membranes. Filters were incubated with digoxigenin-labeled lectins
followed by anti-digoxigenin Fab fragments coupled to alkaline
phosphatase, as specified by the manufacturer’s recommendations.
For digestion of PA2.26 antigen with glycosidases, PA2.26
immunocomplexes were concentrated by cold acetone at - 20°C.
Pellets were solubilized in digestion buffer (30 m l) and treated with
the following glycosidases: 1 U of N-glycosidase F (Boehringer
Mannheim) in 20 mM phosphate buffer, pH 7.2, 5 mM EDTA, 0.5%
Nonidet P-40; 20 mU of neuraminidase from C. perfringens (Sigma
Chemical Co) in 50 mM acetate buffer, pH 5.5; 1 mU of
O-glycosidase (Boehringer Mannheim) in 20 mM phosphate
buffer, pH 6.0, 0.1% Triton X-100. Incubations were for 2 hours
(neuraminidase) or overnight (N-glycosidase F, O-glycosidase) at
37°C.
Purification of PA2.26 antigen and amino acid sequence
analysis
The membrane fraction of mouse brain extracts was used as the source
of PA2.26 antigen. Collected brains were cut into several pieces and
homogenized in ice-cold 20 mM Hepes, pH 7.2, plus protease
inhibitors. The homogenate was passed through several pieces of
gauze, layered on the top of a discontinuous 0.8 M and 1.2 M sucrose
gradient, and centrifuged at 140000 g for 1 hour. The interface fraction
was diluted in 20 mM Hepes, pH 7.2, centrifuged at 140000 g for 1
hour, and the pellet lysed in buffer A containing 0.1% SDS and
protease inhibitors. The lysate was precleared by passing through a
column of rat IgG-Sepharose 4B equilibrated in buffer A and then
loaded onto a column of mAb PA2.26-Sepharose 4B previously
equilibrated in buffer A. The column was washed sequentally with
buffer A and buffer A containing 0.5 M NaCl, and PA2.26 antigen
eluted with buffer B (10 mM Hepes, pH 6.8, 0.5 M NaCl, 1% SDS,
2 mM EGTA, 2.5 mM MgCl2) after boiling the beads for 5 minutes.
The supernatant was concentrated with cold acetone at - 20°C, the
pellet resuspended in buffer B and resolved in 10% SDS-PAGE (gel
thickness, 0.75 mm) under nonreducing conditions. A single protein
band migrating at 45 kDa (corresponding to the mature form of
PA2.26 antigen) was excised from the Coomassie blue-stained gel,
soaked in water and processed for internal peptide sequencing in
Eurosequence (Groningen, The Netherlands). 
RT-PCR and molecular cloning of PA2.26 antigen
Based on the sequence information of the OTS-8 cDNA (Nose et al.,
1990), two oligonucleotides were generated flanking the coding
sequence of OTS-8: the sense primer 5 ¢ -AAAAACCCACTA-
GCTGCTGAGGCTCCAA-3 ¢ and the antisense primer 5 ¢ -ATGG-
GTCATCTTCCTCCACAGGAAGAGG-3 ¢ . Reverse transcription
was performed at 42°C for 1 hour using the enzyme from avian
F. G. Scholl and others
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myeloblastosis virus (Promega, Madison, WI), 100 ng of a poly(A)+-
enriched RNA fraction (Mini RiboSep; Becton Dickinson Labware,
Bedford, MA) extracted from the cell lines, as templates, and random
hexameres as primers. The products of the reactions were tenfold
diluted and used for PCR (30 cycles: 94°C for 1 minute, 55°C for 2
minutes and 72°C for 3 minutes) in a Gene Amp PCR system 2400
(Perkin Elmer, Foster City, CA). The resulting 659 bp cDNA
fragment was cloned into pGEM-t (Promega) and sequenced in both
directions. 
cDNA transfection
The cDNA coding for PA2.26 antigen was subcloned into the
expression vector pcDNA3 (InVitrogen, San Diego, CA), downstream
from the cytomegalovirus promoter. 
For transient transfections, cells were seeded on glass coverslips 24
hours before DNA transfer. Cells were transfected using lipofectamine
reagent (Gibco BRL, Gaithesburg, MD) and analyzed for
immunofluorescence 36 hours after.
For stable transfection of MCA3D keratinocytes, cells cultured on
plates were processed as mentioned above. Transfected cells were
selected by growing in medium containing 0.4 mg/ml of G418 for 3-
4 weeks, and individual clones isolated by cloning rings. 
Infection/transfection experiments were performed as previously
described (García-Gallo et al., 1999). Briefly, COS cells were infected
with vTF7-3 virus at a multiplicity of four plaque-forming units per
cell, for 1 hour at 37°C. After adsorption, virus inoculum was
removed, cells were washed once in Dulbecco’s modified Eagle’s
medium containing 2% foetal calf serum, and transfected using
lipofectamine reagent. 
Immunofluorescence microscopy
For single- and double-staining immunofluorescence microscopy
analysis, cells grown on glass coverslips were fixed with 3.7%
formaldehyde in PBS and permeabilized with 0.05% Triton X-100 for
10 minutes. Coverslips were soaked in PBS containing 1% BSA and
incubated with the indicated antibodies for 1 hour at 37°C in a moist
chamber. FITC-labeled goat anti-rat IgG or rhodamine-conjugated
goat anti-rabbit IgG (Jackson, West Grove, PA) were used as
secondary antibodies. For F-actin staining, phalloidin coupled to
rhodamin compound was used. Coverslips were then mounted in
mowiol and examined with a fluorescence microscope (Axiophot;
Carl Zeiss, Oberkochen, Germany).
Confocal microscopy analysis was carried out as previously
described (Pagan et al., 1996) in a confocal scanning laser microscope
(TCS 4D; Leica Lasertechnik GmbH, Heidelberg, Germany) adapted
to an inverted Leitz DMIRBE microscope equipped with a
krypton/argon laser. From 14 serial optical sections for each
fluorochrome, made through a depth of 7 m m inside the specimen
(except for Fig. 9, in which four serial optical sections were made
through a depth of 4 m m), a three-dimensional image was assembled
using ImageSpace software.
Electron microscopy
PDV cells grown on Transwell chambers were fixed with 2%
paraformaldehyde in phosphate buffer (PB) for 1 hour at 4°C. After
washing in PB containing 20 mM glycine (PB-G), cells were
incubated with 1% BSA in PB-G for 10 minutes at room temperature.
Cells were stained with mAb PA2.26, followed by incubation with
rabbit anti-rat IgG and 15-nm colloidal gold-labeled protein A (British
Bio Cell, Cardiff, UK). Each of these incubations were in blocking
solution for 1 hour at room temperature. Cells were post-fixed with
2% paraformaldehyde, 2.5% glutaraldehyde in PB buffer. The
polycarbonate membrane was excised from the Transwell chamber,
treated with 2% osmium tetroxide, dehydrated in ethanol and
embedded in Spurr as previously described (Casaroli-Marano et al.,
1998). Ultrathin sections (30-50 nm) were observed and
photographied by conventional TEM (Hitachi 600 AB).
Immunohistochemistry
Organ specimens of adult mice were obtained, fixed in formalin and
embedded in paraffin. Immunostaining for PA2.26 antigen was
performed by the avidin-biotin-alkaline phosphatase method in
deparaffinized sections after heat-induced antigen retrieval, as
previously described (Palacios and Gamallo, 1998).
Migration assay
Confluent cell monolayers were gently scratched with a tip to produce
a wound. Then, cultures were allowed to grow for 24 hours in the
Fig. 1. Biochemical characterisation of PA2.26 antigen. (A) Phase
separation of PA2.26 antigen. The membrane fraction of PDV cells
was extracted with the detergent Triton X-114. After centrifugation,
the pellet was solubilized in Laemmli buffer (lane 1) and the
supernatant subjected to temperature-induced phase separation
resulting in organic (lane 2) and aqueous (lane 3) phases. Samples
corresponding to the same number of cells were run on 10% SDS-
PAGE and immunoblotted with PA2.26 mAb. (B) Treatment with PI-
PLC. 125I-labeled PDV cells were incubated in culture medium alone
(lanes 1 and 3) or in medium containing PI-PLC enzyme (lanes 2 and
4). The cell lysates (lanes 1 and 2) and culture media (lanes 3 and 4)
were immunoprecipitated with mAb PA2.26 and resolved by 10%
SDS-PAGE. (C,D) Analysis of glucidic composition of PA2.26
antigen. (C) PA2.26 immunoprecipitates from PDV cells were treated
with N-glycosidase F (N-gly F), neuraminidase (NA) or buffer
(Control). (D) PA2.26 immunoprecipitated from PDV, HaCa4 and
lung extracts was incubated with NA, NA plus O-glycosidase (O-
Gly) or buffer (Control). Samples were run on 10% SDS-PAGE and
probed with PA2.26 mAb or PNA lectin. The positions of molecular
mass markers are shown.
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presence of medium plus serum. Cells invading the denuded area of
the wounds were counted in 3-4 different fields from duplicates.
RESULTS
PA2.26 antigen is an integral mucin-like membrane
protein
mAb PA2.26 recognizes a protein of about 45 kDa on the
surface of mouse skin carcinoma cells (PDV, HaCa4, Car C)
and cultured fibroblasts (NIH3T3, Swiss 3T3). To analyse the
association of the antigen to the plasma membrane, the
membrane fraction of PDV carcinoma cells was extracted with
the detergent Triton X-114. After phase separation, hydrophilic
proteins are found in the aqueous phase while integral
membrane proteins with an amphiphilic nature are recovered
in the detergent phase (Bordier, 1981). PA2.26 antigen was
recovered in the organic phase (Fig. 1A, lane 2) and no
detectable signal was observed neither in the insoluble fraction
nor in the aqueous phase (Fig. 1A, lanes 1 and 3, respectively).
Moreover, treatment of 125I surface-labeled PDV cells with
phosphatidylinositol-phospholipase C (PI-PLC) did not
liberate the antigen into the culture medium (Fig. 1B),
indicating that the protein is not attached to the membrane by
a glycosil phosphatidylinositol anchor. 
The broadness of the bands indicated that PA2.26 protein
could be glycosylated. Therefore, we analysed the presence of
specific carbohydrates using a set of digoxigenin-labeled
lectins (Table 1). The intact antigen immunoprecipitated from
PDV cells only bound MAA, indicating the presence of sialic
acid (SA) linked a (2-3) to galactose, while it did not react with
SNA, which also recognizes SA residues but a (2-6)-linked.
Removal of SA residues by digestion with neuraminidase (NA)
resulted in a shift in mobility from 45 kDa to 40 kDa
and allowed binding of PNA, but not of other lectins, to the
antigen (Fig. 1C, Table 1). PNA recognizes the unsubstituted
disaccharide galactose b (1-3)N-acetylgalactosamine in O-
glycans, and its positive reaction to neuraminidase-treated
PA2.26 suggested the presence of O-linked carbohydrates in
the protein. In fact, digestion of the desialylated antigen with
O-glycosidase (O-Gly) yeld a further reduction of molecular
mass to 27 kDa, as shown in Fig. 1D for PA2.26
immunoprecipitated from PDV and HaCa4 cell lines.
Digestion with N-glycanase F (N-Gly F) did not change the
mobility of the protein (Fig. 1C), indicating the absence, or
minor presence, of N-linked sugars. 
PA2.26 antigen is also expressed in normal mouse tissues
such as brain and lung (see below). The protein recognized by
the mAb PA2.26 in brain had a similar size, 45 kDa, to that
detected in cultured cells (not shown), while the lung protein
had a smaller molecular mass of about 42 kDa (Fig. 1D). This
difference in size is likely due to a lesser degree of sialylation,
as digestion of PA2.26 immunoprecipitated from lung extracts
with neuraminidase shifted the mobility of the protein to 40
kDa and combined treatment with neuraminidase and O-
F. G. Scholl and others
Table 1. Lectin binding analysis of immunoprecipitated
PA2.26 antigen
Binding to
Chains Intact Antigen
Lectin Specificity recognized antigen + NA
GNA High mannose N-glyc – –
SNA SAa (2-6)-Gal N- and O-glyc – –
MAA SAa (2-3)-Gal N- and O-glyc + –
PNA Gal b (1-3)GalNAc O-glyc – +
DSA Gal b (1-4)GlcNAc N- and O-glyc – –
AAA Fuc O-glyc – ND
Immunoprecipitated PA2.26 antigen was separated by SDS-PAGE before
and after digestion with neuraminidase (NA) and blotted to Immobilon P. The
blot was probed with the indicated lectins conjugated with digoxigenin and
visualized with an anti-digoxigenin antibody coupled to alkaline phosphatase.
SA, sialic acid; Gal, galactose; GalNAc, N-acetylgalactosamine; GlcNAc, N-
acetylglucosamine; Fuc, fucose; ND, not determined.
Fig. 2. Immunofluorescence colocalization of PA2.26 antigen with F-
actin and ezrin in carcinoma and fibroblast cell lines. 
(A-D) Colocalization of PA2.26 and F-actin in PDV (A,B) and Car C
(C,D). Cells were doubly stained with PA2.26 mAb (A,C) and
phalloidin (B,D). C and D show confocal images. 
(E-H) Colocalization of PA2.26 and ezrin in PDV (E,F) and Swiss
3T3 (G,H) by confocal analysis. Cells were doubly stained with
PA2.26 mAb (E,G) and an anti-ezrin polyclonal antibody (F,H).
Arrowheads indicate lamellipodia and ruffles, and arrows filopodia.
Bar, 10 m m.
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glycosidase again yielded a band of
27 kDa (Fig. 1D), as found above in
cultured cells.
Overall, these data demonstrate
that PA2.26 antigen is a highly
glycosylated, mucin-like, integral
membrane protein with an apparent
peptide backbone of about 27 kDa. 
PA2.26 antigen is located in
actin-containing plasma
membrane projections where it
colocalizes with ERM proteins
Immunofluorescence analysis of
PA2.26 in cultured cells revealed an
intense staining in plasma membrane
projections such as lamellipodia
and ruffles (Fig. 2A,C,E,G). Double-
staining fluorescence microscopy
with mAb PA2.26 and phalloidin in
PDV cells showed a colocalization of
PA2.26 protein with actin filaments
of lamellipodia and membrane
projections from the leading edge, but
the antigen seemed to be excluded
from cortical actin bundles and stress
fibers (Fig. 2A,B). These results were
confirmed by confocal microscopy
studies, as shown for the spindle
carcinoma cell line Car C (Fig.
2C,D). These highly motile cells
(Buchmann et al., 1991) exhibit
prominent membrane ruffles rich in
actin filaments (Fig. 2D), which were
intensely stained with mAb PA2.26
(Fig. 2C). In addition, a punctate
staining all along the cells located on the plasma membrane was
also observed (see Fig. 2C). Similar results were obtained with
NIH3T3 and Swiss 3T3 fibroblast cell lines (data not shown).
ERM proteins function as linkers between the actin
cytoskeleton and the plasma membrane (see Tsukita et al.,
1997; Mangeat et al., 1999, for reviews). They are concentrated
at microvilli and other actin-rich surface structures in a wide
variety of cells. Particularly, ezrin is found primarily in
epithelial cells (Berryman et al., 1993). Therefore, we studied
the possible colocalization of PA2.26 and ezrin in the cell lines
by confocal microscopy (Fig. 2E-H). The pattern of ezrin
staining in microvilli, membrane ruffles and lamellipodia was
very similar to that seen for PA2.26 in PDV (Fig. 2E,F), and
Swiss 3T3 cells (Fig. 2G,H). PA2.26 antigen also colocalized
with moesin and radixin in these cultured cells, as
demonstrated by double-staining immunofluorescence
experiments (data not shown).
To examine the location of PA2.26 at the ultrastructural
level, immunogold preembedding staining and electron
microscopy studies were performed in PDV cells grown on
Transwell chambers to preserve cell polarity (Fig. 3). PA2.26
protein was highly concentrated over membrane microvilli.
Gold particles were distributed all along their surfaces (Fig.
3A,B), and only a minor fraction of gold particles appeared as
clusters in planar regions of the plasma membrane (see arrow
in Fig. 3C). No staining was observed on the basal membrane
in contact with the substratum (Fig. 3C).
To analyse whether the antigen and ERM proteins associate
in the cells, PA2.26 was immunoprecipitated from PDV lysates
and the presence of ezrin, radixin and moesin assessed by
western immunoblotting with specific antibodies (Fig. 4). In
parallel, we carried out the same analysis with MCA3D cells,
which do not express the antigen, as a control. Both MCA3D
and PDV cell lines synthesize the three proteins of the ERM
Fig. 3. (A-C) Immunoelectron
microscopic localization of PA2.26
antigen at membrane microvilli of PDV
cells. Arrow in (C) shows clusters of
colloidal gold particles associated with
planar regions of the membrane. Bars,
0.1 m m (A,B); 0.2 m m (C).
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family, as found by western analysis of cell lysates (Fig. 4,
lanes 1-4). Protein bands corresponding to ezrin and moesin,
but not radixin, could be detected in the PA2.26
immunoprecipitates from PDV cells lysed in 1% Triton X-100
(Fig. 4, lane 6). However, when cells were lysed in RIPA
buffer neither ezrin nor moesin were present in the
immunoprecipitates (Fig. 4, lane 8).
Distribution of PA2.26 protein in tissues
The expression of PA2.26 was examined in different mouse
tissues by western immunoblotting. The protein was present at
relatively high levels in lung and brain, and to a lesser extent
in kidney, stomach, liver and oesophagus. No significant
expression was found in skin, muscle and small intestine (data
not shown).
Immunohistochemical staining in tissue sections revealed
the presence of PA2.26 in different types of cells (Fig. 5). In
the lung, the alveolar epithelium was intensely stained, while
epithelial cells of the terminal bronchiole were negative (Fig.
5A). The choroid plexuses and ependymal epithelia expressed
PA2.26 located at microvilli facing the ventricular cavity (Fig.
5B,C). All pleural, pericardial and peritoneal mesothelia
examined were also positive with PA2.26 concentrated on the
apical cell surface (see Fig. 5D,F). Endothelial cells from
veins, arteries and endocardium were not stained (Fig.
5A,E,F,F¢ ) and, surprisingly, the only positive endothelial cells
were sited in the lymphatic capillaries, as can be observed in
the small intestine (Fig. 5D) and liver (Fig. 5E). Noteworthy,
cells of the intestinal mucosa did not express PA2.26 (Fig. 5D),
nor did smooth muscle (Fig. 5D), skeletal (not shown) and
cardiac (Fig. 5F,F ¢ ) cells. In the kidney, PA2.26 was found in
podocyte cells of the glomeruli (Fig. 5G) and in the parietal
epithelial cells of Bowman’s capsule (not shown).
Identification and cloning of PA2.26 antigen 
PA2.26 antigen was purified by affinity chromatography from
the membrane fraction of mouse brain extracts, as described
in Materials and Methods. A single band of 45 kDa
corresponding to PA2.26 was obtained in the final eluate, and
its area excised from the gel and processed for internal peptide
sequencing. Two major peptides of 8 and 7 amino acids were
separated by reverse-phase HPLC after tryptic digestion of the
protein, and their amino acid sequences determined by Edman
degradation (Fig. 6A). A search in the EMBL data base
identified two mouse proteins, OTS-8 and gp38, containing
amino acid sequences that matched that of the peptides (Fig.
6A). OTS-8 was isolated as a PMA-inducible gene from an
osteoblastic cell line (Nose et al., 1990) and gp38 was cloned
from thymus epithelial cells (Farr et al., 1992). Several
differences due to single nucleotide changes could be observed
on comparing the predicted amino acid sequences of both
cDNAs. The main change was a T nucleotide at the 3¢ end of
the gp38 sequence, absent in the OTS-8 cDNA, that shifted the
stop codon position such that the deduced cytoplasmic domain
of the OTS-8 protein is 32 residues longer than that of gp38.
Appropiate 5¢ and 3¢ oligonucleotides flanking the open
reading frame of the OTS-8 cDNA were synthesized and used
for RT-PCR experiments. A band of 659 bp was amplified
using poly(A)+ RNA from PDV, HaCa4 and NIH3T3 cell lines
(Fig. 6B, lanes 2, 3 and 4, respectively), while no mRNA could
be detected in MCA3D cells (Fig. 6B, lane 1). These data
confirm our early assumption that PA2.26 antigen is not
expressed in nontumorigenic MCA3D keratinocytes, as mAb
PA2.26 was unreactive in this cell line (Gandarillas et al.,
1997). The PDV RT-PCR-amplified cDNA fragment was
cloned and sequenced (Fig. 6C). The sequence was almost
identical to that reported for OTS-8 cDNA (Nose et al., 1990),
the only difference being a single T nucleotide insertion at
position 547 that results in a change of frame from amino acid
170 and originates a stop codon at position 555 giving rise to a
shorter C-terminal end, as occurred with gp38 (Farr et al., 1992).
The PDV cloned cDNA encoded a protein of 172 amino acids
that included the two microsequenced peptides (underlined). It
contains an N-terminal signal sequence with a putative cleavage
site between amino acids 22 and 23. The mature protein has a
predicted molecular mass of 18.2 kDa. A presumptive
membrane-spanning domain (residues 135-163, shaded) is
located near the C terminus followed by a short cytoplasmic tail
of only 9 amino acids. A serine within this latter domain at
position 167 is part of a potential cAMP and protein kinase C-
dependent phosphorylation site. The extracellular domain
contains only a putative N-glycosylation site at position 60
whereas potential O-glycosylation serine or threonine residues
are very abundant. These data are in agreement with PA2.26
antigen being a type-I membrane mucin-like protein. 
To confirm that this sequence encoded PA2.26 antigen, COS
cells were infected with high multiplicity of the recombinant
vTF7-3 virus and transfected with the PDV cDNA cloned in
the pcDNA3 vector, to allow maximal expression of the
protein. The mAb PA2.26 detected in western blots a doublet
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Fig. 4. Coimmunoprecipitation of ezrin and moesin with PA2.26
antigen. MCA3D (lanes 1, 3, 5 and 7) and PDV (lanes 2, 4, 6 and 8)
cells were lysed in a buffer containing 1% Triton X-100 (lanes 1, 2, 5
and 6) or buffer RIPA (lanes 3, 4, 7 and 8). The presence of ERM
proteins and PA2.26 antigen was determined in the lysates by
western immunoblotting with anti-ezrin 3C12 mAb, anti-radixin and
anti-moesin polyclonal antibodies, and PA2.26 mAb (lanes 1-4).
Lysates were immunoprecipitated with PA2.26 mAb and the
immunocomplexes resolved by 7.5% SDS-PAGE and immunoblotted
with the above antibodies (lanes 5-8). Bands in lanes 5 and 7 of the
lower panel correspond to the heavy chain of immunoglobulin.
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of 27 kDa corresponding to the core
protein, an intermediate species of 30
kDa, and the mature glycosylated
form of 45 kDa (Fig. 7, left
panel). Similar results were obtained
in infected/transfected MCA3D
cells (data not shown).
Immunofluorescence analysis in COS
cells, and in immortalized mouse
MCA3D and human HaCaT
keratinocytes, transiently transfected
with the PA2.26 cDNA, localized
the antigen concentrated at ruffles,
lamellipodia and microvilli (Fig. 7A-
D). Some keratinocytes expressing
PA2.26 antigen seemed to acquire a
motile phenotype with increased
membrane ruffling activity and
formation of a leading edge in which
the antigen was present (see Fig. 7C).
Transfection of PA2.26 antigen
into MCA3D keratinocytes
induces a change in
morphology concomitantly to a reorganization of
the actin cytoskeleton and increased motility
To study further the effect of PA2.26 antigen on the phenotype
of keratinocytes, we obtained stable transfectants of MCA3D
cells. Ten clones were selected and the expression of PA2.26
analysed by northern and western blots. All the transfectants
expressed a mRNA of around 1.2 kb (Fig. 8A, lanes 3-12),
absent in cells transfected with the empty vector (Fig. 8A, lane
2). Transformed PDV and HaCa4 keratinocytes expressed one
species of RNA of 1.9 kb corresponding to the endogenous
PA2.26 mRNA (Fig. 8A, lanes 13, 14). Low levels of PA2.26
protein expression were found in the transfectants when
compared with NIH3T3 fibroblasts (Fig. 8B, compare lanes 2-
7 with lane 8) or transformed keratinocytes (not shown). mAb
PA2.26 recognized in the lysates a protein of 40 kDa in
addition to the 45 kDa form (Fig. 8B, lanes 2-7). This protein
of lower molecular mass is likely to represent an incompletely
glycosylated antigen since immunoprecipitates from biotin-
labeled cell surface transfectant clones contained only the
mature form of 45 kDa (data not shown). 
Expression of PA2.26 antigen in MCA3D keratinocytes
induced a dramatic change in cell morphology (Fig. 8C).
Parental MCA3D cells and control clones grew as islands with
strong cell-cell contacts, exhibiting the typical paving stone
appearance of epidermal keratinocytes at confluence (Fig. 8C,
left). In contrast, PA2.26 transfectants showed an elongated
morphology with numerous membrane protrusions, and were
unable to grow as colonies of cohesive cells even at high cell
Fig. 5. Immunohistochemical
localization of PA2.26 antigen in tissue
sections. (A) lung; (B) choroid plexus;
(C) ependymum; (D) small intestine; (E)
liver; (F,F ¢ ) heart; (G) kidney. Intense
staining is found in the epithelia of
alveoli (A), choroid plexuses (B),
ependyma (C) and glomeruli (G), in
lymphatic vessel (lv) endothelia, and
peritoneal (pe) and pericardial (p)
mesothelia (see D-F). Some cells of the
biliar ducts (bd) are also weakly stained
in E. No staining is found in endothelial
cells of the endocardium (e, see F¢ ),
portal vein (pv) and other veins (v) and
arteries (a), nor in smooth (D) and
cardiac (F,F ¢ ) muscle cells, or in cells of
the intestinal mucosa (D) and kidney
tubules (G; the background staining seen
in this section is due to endogenous
biotin). Note that PA2.26 antigen is
clearly located at the plasma membrane
(A) and microvillous projections (B,C).
Bar, 10 m m (A-C, F,F ¢ ), 20 m m (D,E,G). 
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density (Fig. 8C, right). Confocal imaging of cells
doubly stained with phalloidin or anti-ezrin antibody
and mAb PA2.26 revealed a gross perturbation of the
actin cytoskeleton in PA2.26 transfectants (Fig. 9).
Phalloidin staining in MCA3D and control clone
3DN5 showed the presence of strong cortical actin
bundles and stress fibers (Fig. 9A) that dissapeared
in 3D2.26 transfectants (Fig. 9B). Phalloidin
staining in these cells was diffuse and concentrated
at the cell periphery in projections and ruffles that
emerged from the lateral surfaces at cell-cell
boundaries, where a clear colocalization between
actin filaments and PA2.26 antigen was observed
(Fig. 9B,C, arrowhead). On the other hand, ezrin
was distributed as a punctate staining throughout
(underneath) the plasma membrane in the parental
cells and control clones (Fig. 9D), while in 3D2.26
transfectants it was concentrated with PA2.26 in
filopodia and ruffles (Fig. 9E,F, arrows and
arrowheads, respectively). No differences in the
level of expression of ezrin were observed between
the control and 3D2.26 cells, as ascertained by
western immunoblotting (data not shown).
To test whether the observed phenotypic changes in 3D2.26
transfectants correlated with increased motility, we used a
wound healing assay in which the abilities of the cell lines to
repopulate a wound made in
confluent cultures were compared.
As shown in Fig. 10, only a few
cells from MCA3D and control
clones were able to migrate but
remained very close to the wound lining (Fig. 10A,C,E). In
contrast, a substantial proportion of 3D2.26 transfectant cells
invaded the empty area of the wound (Fig. 10B,D,E). This
effect can not be attributed to increased proliferation, since no
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Fig. 6. Molecular cloning of PA2.26 cDNA. (A) Amino
acid sequences of two peptides obtained from the
purified antigen showing homologies with OTS-8/gp38
proteins. (B) Poly(A)+ RNA from MCA3D (lane 1),
PDV (lane 2), HaCa4 (lane 3) and NIH 3T3 (lane 4) cells
were subjected to RT-PCR with OTS-8 (upper panel) or
b -actin (lower panel) oligonucleotides. (C) Nucleotide
sequence of PA2.26 cDNA and amino acid sequence of
the encoded protein. The two peptides originally
identified by microsequencing are underlined. The
putative membrane-spanning domain is shaded.
Accession number: AJ250246 (EMBL).
Fig. 7. Analysis of cells transiently
transfected with the PA2.26 cDNA. In
the left panel, the expression of
PA2.26 protein in COS cells
infected/transfected with the empty
vector (lane 1) and PA2.26 cDNA
(lane 2) is analyzed by western
immunoblotting. The right panels
present the immunofluorescent
localization of PA2.26 in cell lines
transiently transfected with PA2.26
cDNA. (A,B) COS; (C) MCA3D; (D)
HaCaT. Images in A and B show the
same field with the plane of focus
adjusted at the bottom and the upper
part of the cells, respectively.
Arrowheads indicate prominent
membrane ruffles. Bar, 10 m m.
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significant differences in growth properties (rather 3D2.26
clones exhibited a slightly slower rate of growth) were
observed between 3DN and 3D2.26 cell lines (data not shown).
DISCUSSION
In this report we have identified and cloned a type I membrane
mucin-like glycoprotein that localizes at cell surface
projections of cultured mouse carcinoma cells and fibroblasts.
This protein is recognized by mAb PA2.26, produced against
transformed epidermal keratinocytes, and is induced during
wound healing and skin carcinogenesis, as previously
described (Gandarillas et al., 1997).
The amino acid sequence of PA2.26 antigen exhibits a high
homology with two previously described mouse proteins, OTS-
8 and gp38, identified as a phorbol ester-inducible gene in
cultured osteoblasts and as a marker of stromal cells in T-cell
dependent areas of peripheral lymphoid tissue, respectively
(Nose et al., 1990; Farr et al., 1992). The rat (T1 a /E11/
podoplanin) and canine (gp40) homologs of murine OTS-
8/gp38/PA2.26 have also been described by different groups
(Rishi et al., 1995; Wetterwald et al., 1996; Breiteneder-Geleff
et al., 1997; Zimmer et al., 1997). All of them synthesize type
I transmembrane proteins of around 170 amino acids with
highly homologous short cytoplasmic domains of nine
residues, except for OTS-8 where a longer endodomain of 42
amino acids has been reported (Nose et al., 1990). The different
mouse proteins are likely encoded by the same gene and
discrepancies in the reported cDNA sequences, particularly the
longer open reading frame reported for OTS-8 cDNA, are
probably due to sequencing errors. In the rat, T1a
sialoglycoprotein was first described as a marker of alveolar
type I epithelial cells of the lung (Rishi et al., 1995). E11
antigen was found to be present in rat osteoblasts, osteocytes,
alveoli, choroid plexuses and endothelia of lymphatic vessels
(Wetterwald et al., 1996). Most recently, podoplanin has been
identified in glomerular epithelial cells (podocytes) associated
to a experimentally induced nephropathy (Breiteneder-Geleff
et al., 1997). In the dog, gp40 was described as a major apical
cell-surface sialoglycoprotein of type I MDCK cells (Zimmer
et al., 1997). Although a role for canine gp40 as a receptor for
influenza C virus has been proposed (Zimmer et al., 1995), and
speculations about the participation of T1 a in active ion
transport and water fluxes were postulated (Williams et al.,
1996), the function of all these proteins is unknown. 
In this article, we present experimental evidence that points
to an involvement of PA2.26 in the organization of the actin
cytoskeleton in dynamic membrane structures associated with
motility processes.
The actin cytoskeleton has been implicated in many cellular
functions, including chemotaxis and motility (Condeelis, 1993;
Fig. 8. Morphological change induced by stable transfection of PA2.26 cDNA into MCA3D keratinocytes. (A) Northern blot analysis of PA2.26
expression. Lane 1, parental MCA3D cells; lane 2, control clone 3DN5; lanes 3-12, PA2.26-transfected clones (3, 3D2.26-1; 4, 3D2.26-2; 5,
3D2.26-3; 6, 3D2.26-4; 7, 3D2.26-6; 8, 3D2.26-7; 9, 3D2.26-10; 10, 3D2.26-11; 11, 3D2.26-12; 12, 3D2.26-13); lane 13, PDV; lane14, HaCa4.
20 m g of total RNA was loaded per lane. (B) Western blot comparing the expression of PA2.26 protein in NIH3T3 and MCA3D cell
transfectants. Lanes are: 1, 3DN5; 2, 3D2.26-1; 3, 3D2.26-2; 4, 3D2.26-3; 5, 3D2.26-4; 6, 3D2.26-6; 7, 3D2.26-11; 8, NIH3T3. Samples of cell
extracts containing the same amount of protein (30 m g) were fractioned by 10% SDS-PAGE and immunoblotted with mAb PA2.26. (C) Phase-
contrast micrographs of control clone 3DN5 (left) and a representative PA2.26-transfected clone: 3D2.26-2 (right). The rest of the 3D2.26 cell
transfectant clones exhibit a similar morphology. Bar, 20 m m.
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Mitchison and Cramer, 1996). In epithelial cells, the precise
organization of actin filaments is involved in cell-cell and cell-
substratum adhesion and in the maintenance of cell shape
(Gumbiner, 1996; Drubin and Nelson, 1996). Cell locomotion
implies a change in the dynamic of cell surface with extension
and retraction of plasma membrane projections (i.e. filopodia,
lamellipodia and ruffles), mediated by the assembly and
disassembly of actin filaments (Mitchison and Cramer, 1996;
Welch et al., 1997).
PA2.26 is concentrated in actin-rich filopodia, lamellipodia
and ruffles of cultured carcinoma and fibroblast cells, but
seems to be excluded from stress fibers and cortical actin
bundles involved in cell adhesion (Fig. 2). By electron
microscopy, PA2.26 is found in other actin-rich structures as
membrane microvilli (Fig. 3). Additional data from our
laboratory (F. G. Scholl and M. Quintanilla, unpublished
results) support this contention: PA2.26 was induced in serum-
starved quiescent Swiss 3T3 cells by PMA and bradykinin,
which promote the formation of ruffles and filopodia,
respectively, but not by lysophosphatidic acid, which leads to
the assembly of stress fibers and focal adhesion formation
(Ridley and Hall, 1992; Ridley et al., 1992; Kozma et al.,
1995). 
Interestingly, PA2.26 colocalizes with ERM proteins in
plasma membrane extensions of cultured cells (Fig. 2).
Furthermore, the tissue distribution of PA2.26 (Fig. 5)
coincides with that of either ezrin or moesin in the same type
of cells and subcellular structures, although there are tissues
where ezrin is strongly expressed and PA2.26 is absent, such
as the intestinal epithelia. Notably, coinciding with PA2.26,
ezrin has been found on the apical surface of epithelial cells of
the choroid plexus and glomerulus, and on microvilli of
mesothelia covering organs of the pleural, visceral and
peritoneal cavities, while moesin is enriched in endothelial
cells and in certain polarized epithelial cells such as that of
alveoli (Berryman et al., 1993; Amieva et al., 1994; Schwartz-
Albiez et al., 1995; Bohling et al., 1996). On the other hand,
ezrin and moesin, but not radixin, were coimmunoprecipitated
with PA2.26 from 1% Triton X-100 cell lysates, suggesting an
association of these proteins in a complex inside the cells.
Nevertheless, the association between PA2.26 and ezrin/
moesin appeared to be weak since the complex was disrupted
in a stronger lysis buffer (RIPA). 
ERM proteins act as universal linkers between the actin
cytoskeleton and integral proteins of the plasma membrane (i.e.
CD44, CD43, ICAM-2) and appear to have a dynamic role in
the formation and maintenance of cellular structures involving
actin filaments, such as surface microvilli (Takeuchi et al.,
1994; Tsukita et al., 1994; Helander et al., 1996; Yonemura et
al., 1999), and in integrating signals elicited by motogenic/
morphogenic growth factors in epithelial cells (Crepaldi et al.,
1997). The regions of CD44, CD43 and ICAM-2 responsible
for the binding to ERM proteins have been located in a juxta-
membrane cluster of positively charged amino acids
(Yonemura et al., 1998). The short cytoplasmic domain
(KKISGRFSP) of PA2.26 contains three basic amino acids
(two lysines and one arginine), whereas the rest are uncharged
polar or nonpolar residues. The calculated isoelectric point of
the whole domain is 11.17, indicating a net positive charge at
neutral pH. This cluster of basic amino acids in the
endodomain is shared by other transmembrane proteins of
microvillal location such as 5T4 oncofetal antigen (Myers et
al., 1994; Carsberg et al., 1995), L-selectin (Picker et al., 1991)
and ICAM-1 (Carpén et al., 1992). However, the functional
importance of the ERM-binding site for directing protein
distribution at microvilli is unclear since mutation of the basic
cluster has no effect on CD44 localization to membrane
projections (Legg and Isacke, 1998). Experiments with
gluthation-S-transferase-PA2.26 fusion constructs, and of site-
directed mutagenesis, aimed at evaluating the direct interaction
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Fig. 9. Immunofluorescence
colocalization of PA2.26
antigen with F-actin and
ezrin in 3D2.26 cell
transfectants. Control clone
3DN5 (A,D) was stained
with phalloidin (A) and anti-
ezrin polyclonal antibody
(D). PA2.26-transfected
clones 3D2.26-11 (B,C) and
3D2.26-4 (E,F), were doubly
stained with phalloidin (B)
and mAb PA2.26 (C) or anti-
ezrin antibody (E) and mAb
PA2.26 (F). All panels show
confocal images.
Arrowheads indicate ruffles
formed between two adjacent
cells and arrows mark
filopodia. Bar, 10 m m.
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of PA2.26 with recombinant ERM proteins and the importance
of the endodomain in localization of the antigen at the plasma
membrane, are currently in progress.
Biochemical characterization and nucleotide sequence
prediction of PA2.26 reveal that it is a sialylated
transmembrane glycoprotein with an ectodomain rich in
serines and threonines. This extracellular domain has an
extended and rigid structure with a net negative charge as a
result of extensive O-glycosilation, characteristic of mucin-like
glycoproteins (see Hilkens et al., 1992; Gendler and Spicer,
1995, for reviews). Increased levels of expression of
membrane-associated mucins, such as episialin (MUC1)
(Ligtenberg et al., 1990), epiglycanin (Kemperman et al., 1994)
and sialomucin ASGP-1 (Carraway et al., 1992), have been
linked to cancer and metastasis. Overexpression of episialin,
epiglycanin and sialomucin in cultured cells inhibit cell-cell
and cell-substratum adhesion (Kemperman et al., 1994;
Wesseling et al., 1995, 1996; Komatsu et al., 1997). The anti-
adhesive function of these mucins is a consequence of steric
hindrance of cell adhesion receptors due to their large
ectodomains consisting of repetitive mucin-like sequences. In
contrast, based in the assumption that in a mucin-like domain
20-amino acids residues are approximately 5-nm long (Jentoft,
1990), the estimated size of PA2.26 ectodomain is 33 nm, a
value that is in the range of cell adhesion receptors (Becker et
al., 1989; Hynes, 1992). 
Immortalized MCA3D keratinocytes are cohesive,
nonmotile cells and show a characteristic actin cytoskeleton
formed by strong cortical bundles and stress fibers (Caulín et
al., 1995; Gómez et al., 1994-95; this paper). Transfection
experiments show that expression of PA2.26 in MCA3D
keratinocytes leads to alteration of cell-cell adhesion and
induction of plasma membrane extensions and ruffles,
concomitantly to a profound reorganization of the actin
cytoskeleton and redistribution of ezrin to membrane
projections (Fig. 9), indicating a change in the balance of
forces within the cytoskeleton that control cell shape. Although
transmembrane mucins alter cell shape and adhesion, the short
ectodomain of PA2.26 rather indicates that the effects on the
actin cytoskeleton and cell morphology can be mediated by the
transmembrane and/or cytoplasmic domains. The fact that, in
3D2.26 transfectant cells, PA2.26 colocalizes with actin and
ezrin in membrane extensions indicates that a physical
association of PA2.26 with the actin cytoskeleton does indeed
exist, and suggests a mechanism by which PA2.26 can induce
a rearrangement of the actin cytoskeleton by recruitment of
ERM proteins. Therefore, PA2.26 might act as a specialized
membrane anchor for ERM proteins in the cells and tissues in
which the antigen is present. Whether interaction of PA2.26
with ezrin and moesin is direct or indirect through an adaptor
(see Mangeat et al., 1999) is presently unknown, although the
presence of a cluster of basic residues on the cytoplasmic side
next to the transmembrane domain favours the former
possibility. 
The observation that 3D2.26 cells exhibit enhanced motility
properties (Fig. 10), and are tumorigenic upon injection in nude
mice (F. G. Scholl, C. Gamallo and M. Quintanilla, manuscript
in preparation) indicates an active role of PA2.26 in cell
migration and tumorigenesis. Although the molecular
mechanism for the phenotypic changes induced by expression
of PA2.26 in MCA3D cells remains to be investigated, we
speculate that they are mediated by the effects of PA2.26 on
the cytoskeleton. Relocalization of ezrin to microvilli and
ruffles is induced in epithelial cells stimulated by motility
factors (Berryman et al., 1995) and functional inactivation of
ezrin by dominant-negative mutants impairs growth factor-
induced cell migration (Crepaldi et al., 1997). On the other
hand, loss of the cortical actin network (Fig. 9) might account
for destabilization of adherens junctions in 3D2.26 cells (F. G.
Scholl, C. Gamallo and M. Quintanilla, manuscript in
preparation). In support of this, it has been demonstrated that
mechanical tension generated within the cytoskeleton can
regulate cell shape and cause cells to switch between different
genetic programs (Chicurel et al., 1998), and loss of cortical
F-actin and destabilization of adherens junctions have been
shown to contribute to tumor progression (Fischer and Quinlan,
1998).
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Fig. 10. Migration assay. Wounds made in confluent 3DN5 (A) and
3D2.26-4 (B) cell lines were examined after 24 hours of culture (C,
3DN5; D, 3D2.26-4). (E) Diagram showing quantification of the cell
migration assay for the indicated cell lines. Cells invading the wound
area were counted in 3-4 different fields ( · 20) from those shown in
the micrographs. Values are means ± s.d. 
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